Argenx SE(ARGX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARGX Argenx SE

休市中 04-19 16:00:00 EDT

360.23

+1.82

+0.51%

盘后360.23

+0.000.00%

17:28 EDT

最高362.54	最低357.55	成交量33.16万
今开360.38	昨收358.41	日振幅1.39%
总市值213.93亿	流通市值212.14亿	总股本5,939万
成交额1.19亿	换手率0.56%	流通股本5,889万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ARGX","market":"US","secType":"STK","nameCN":"Argenx SE","latestPrice":360.23,"timestamp":1713556800000,"preClose":358.41,"halted":0,"volume":331571,"hourTrading":{"tag":"盘后","latestPrice":360.23,"preClose":360.23,"latestTime":"17:28 EDT","volume":8942,"amount":3221176.66,"timestamp":1713562139763},"delay":0,"floatShares":58890872,"shares":59386542,"eps":-5.161043,"marketStatus":"休市中","marketStatusCode":7,"change":1.82,"latestTime":"04-19 16:00:00 EDT","open":360.38,"high":362.535,"low":357.55,"amount":119243110.8297,"amplitude":0.013909,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.161043,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1713772800000},"adr":1,"listingDate":1495080000000,"adjPreClose":358.41,"adrRate":1,"preHourTrading":{"tag":"盘前","latestPrice":361.83,"preClose":358.41,"latestTime":"09:29 EDT","volume":582,"amount":210593.82492,"timestamp":1713533399098},"postHourTrading":{"tag":"盘后","latestPrice":360.23,"preClose":360.23,"latestTime":"17:28 EDT","volume":8942,"amount":3221176.66,"timestamp":1713562139763},"volumeRatio":1.3535101270152172},"requestUrl":"/m/hq/s/ARGX","defaultTab":"news","newsList":[{"id":"2422616181","title":"Argenx Se涨0.45% 股价突破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2422616181","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422616181?lang=zh_cn&edition=full","pubTime":"2024-03-26 21:31","pubTimestamp":1711459919,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日21时31分，Argenx Se股票出现异动，股价急速拉升0.45%。截至发稿，该股报400.22美元/股，成交量4542股，换手率0.01%，振幅0.34%。Argenx Se股票所在的生物技术行业中，整体涨幅为0.41%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326213159861e13dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326213159861e13dc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422251702","title":"Argenx Se跌1.63% 股价跌破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2422251702","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422251702?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:31","pubTimestamp":1711373507,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时31分，Argenx Se股票出现异动，股价急速跳水1.63%。截至发稿，该股报396.12美元/股，成交量5393股，换手率0.01%，振幅0.13%。Argenx Se股票所在的生物技术行业中，整体跌幅为0.52%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403252131478b6139c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403252131478b6139c6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421063848","title":"Argenx Se涨0.83% 股价突破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2421063848","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421063848?lang=zh_cn&edition=full","pubTime":"2024-03-22 23:06","pubTimestamp":1711119960,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日23时06分，Argenx Se股票出现异动，股价大幅拉升0.83%。截至发稿，该股报400.16美元/股，成交量7.545万股，换手率0.13%，振幅2.71%。Argenx Se股票所在的生物技术行业中，整体跌幅为0.18%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032223060187e7b17a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032223060187e7b17a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415790343","title":"Argenx Se跌2.76% 股价跌破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2415790343","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415790343?lang=zh_cn&edition=full","pubTime":"2024-02-28 23:42","pubTimestamp":1709134962,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日23时42分，Argenx Se股票出现波动，股价快速下跌2.76%。截至发稿，该股报399.86美元/股，成交量7.2368万股，换手率0.12%，振幅1.93%。Argenx Se股票所在的生物技术行业中，整体跌幅为0.34%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402282342427a47c73e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402282342427a47c73e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2412034581","title":"Argenx Se涨3.27% 股价突破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2412034581","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2412034581?lang=zh_cn&edition=full","pubTime":"2024-02-20 22:32","pubTimestamp":1708439565,"startTime":"0","endTime":"0","summary":"北京时间2024年02月20日22时32分，Argenx Se股票出现波动，股价急速拉升3.27%。Argenx Se股票所在的生物技术行业中，整体涨幅为0.36%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。Vyvgart 于2021年12月在美国被批准用于治疗广泛性重症肌无力，随后于2022年在欧洲和日本获得批准。消息层面，截至22时32分，《美国FDA受理Argenx艾加莫德皮下注射用于治疗CIDP的补充上市申请并纳入优先审评》资讯为影响Argenx Se的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022022324587a57d66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022022324587a57d66&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409940434","title":"Argenx Se跌2.37% 股价跌破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2409940434","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409940434?lang=zh_cn&edition=full","pubTime":"2024-02-06 22:32","pubTimestamp":1707229937,"startTime":"0","endTime":"0","summary":"北京时间2024年02月06日22时32分，Argenx Se股票出现波动，股价快速跳水2.37%。Argenx Se股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Invivo Therapeutics Holding Corp、Tenax Therapeutics Inc、Exicure Inc涨幅较大，Tenax Therapeutics Inc、Invivo Therapeutics Holding Corp、Exicure Inc较为活跃，换手率分别为941.95%、549.09%、41.21%，振幅较大的相关个股有Invivo Therapeutics Holding Corp、Tenax Therapeutics Inc、Sagimet Biosciences Inc，振幅分别为85.68%、35.21%、13.60%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402062232178774bd80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402062232178774bd80&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409432067","title":"Argenx Se盘中异动 临近午盘股价大涨5.00%报397.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2409432067","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409432067?lang=zh_cn&edition=full","pubTime":"2024-02-06 00:30","pubTimestamp":1707150627,"startTime":"0","endTime":"0","summary":"北京时间2024年02月06日00时30分，Argenx Se股票出现波动，股价急速拉升5.00%。截至发稿，该股报397.78美元/股，成交量18.4224万股，换手率0.31%，振幅5.05%。Argenx Se股票所在的生物技术行业中，整体涨幅为0.32%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402060030277a418410&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402060030277a418410&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2404056086","title":"隔夜美股全复盘(1.19)| 三大股指高开高收，台积电大涨10%，Q4业绩和下季指引全线超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2404056086","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2404056086?lang=zh_cn&edition=full","pubTime":"2024-01-19 07:25","pubTimestamp":1705620309,"startTime":"0","endTime":"0","summary":"三大股指高开高收，台积电大涨10%，Q4业绩和下季指引全线超预期","market":"hk","thumbnail":"https://img7.gelonghui.com/column/2/140.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/140.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/686019","is_publish_highlight":false,"gpt_icon":0},{"id":"2404237510","title":"日本批准Argenx(ARGX.US)VYVDURA皮下注射剂用于治疗全身型重症肌无力","url":"https://stock-news.laohu8.com/highlight/detail?id=2404237510","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2404237510?lang=zh_cn&edition=full","pubTime":"2024-01-18 15:28","pubTimestamp":1705562906,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，荷兰生物技术公司Argenx(ARGX.US)宣布，日本厚生劳动省批准VYVDURA皮下注射剂用于治疗成人全身型重症肌无力(gMG)。VYVGART现已在日本被批准用于静脉注射和皮下注射。该公司指出，此次批准是基于3期ADAPT-SC研究的积极结果。Argenx日本总经理Hermann Strenger表示：“将VYVDURA引入日本意味着现在有两种药剂可供gMG患者使用，包括在家自行注射，允许患者和他们的医疗保健提供者选择最佳方案来满足治疗需求。”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1057316.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2401957820","title":"Argenx Se涨1.43% 股价突破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2401957820","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2401957820?lang=zh_cn&edition=full","pubTime":"2024-01-08 22:33","pubTimestamp":1704724381,"startTime":"0","endTime":"0","summary":"北京时间2024年01月08日22时33分，Argenx Se股票出现波动，股价大幅上涨1.43%。截至发稿，该股报401.88美元/股，成交量1.0704万股，换手率0.02%，振幅0.81%。Argenx Se股票所在的生物技术行业中，整体跌幅为1.06%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。Vyvgart 于2021年12月在美国被批准用于治疗广泛性重症肌无力，随后于2022年在欧洲和日本获得批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240108223301861c925a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240108223301861c925a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2393348714","title":"Argenx Se盘中异动 股价大涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2393348714","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2393348714?lang=zh_cn&edition=full","pubTime":"2023-12-22 04:50","pubTimestamp":1703191823,"startTime":"0","endTime":"0","summary":"北京时间2023年12月22日04时50分，Argenx Se股票出现波动，股价急速拉升5.25%。截至发稿，该股报356.70美元/股，成交量199.552万股，换手率3.38%，振幅8.55%。Argenx Se股票所在的生物技术行业中，整体涨幅为0.80%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。消息层面，截至04时50分，Argenx Se股票正面舆情新闻比例15.38%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312220450247902c0d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312220450247902c0d8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2386614563","title":"Argenx Se盘中异动 早盘股价大跌8.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2386614563","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2386614563?lang=zh_cn&edition=full","pubTime":"2023-11-28 22:30","pubTimestamp":1701181825,"startTime":"0","endTime":"0","summary":"北京时间2023年11月28日22时30分，Argenx Se股票出现波动，股价大幅下跌8.82%。截至发稿，该股报452.06美元/股，成交量12.7229万股，换手率0.22%，振幅0.00%。Argenx Se股票所在的生物技术行业中，整体跌幅为0.57%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023112822302583a10724&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023112822302583a10724&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2386111388","title":"argenx(ARGX)盘前跌近12% 治疗出血性疾病的药物在试验中失败","url":"https://stock-news.laohu8.com/highlight/detail?id=2386111388","media":"凤凰网港股","top":-1,"share":"https://www.laohu8.com/m/news/2386111388?lang=zh_cn&edition=full","pubTime":"2023-11-28 19:15","pubTimestamp":1701170145,"startTime":"0","endTime":"0","summary":"金吾财讯 | 截至发稿，argenx(ARGX)盘前跌近12%，报438.25美元。消息面上，公司表示，一项初步研究结果显示，该公司唯一一种治疗一种罕见出血性疾病的药物在试验中失败。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=7549df583f9e5bcda89301603c63ae5d","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.argenx.com","stockEarnings":[{"period":"1week","weight":-0.0471},{"period":"1month","weight":0.0092},{"period":"3month","weight":-0.0182},{"period":"6month","weight":-0.2417},{"period":"1year","weight":-0.0521},{"period":"ytd","weight":-0.0531}],"compareEarnings":[{"period":"1week","weight":-0.0307},{"period":"1month","weight":-0.0486},{"period":"3month","weight":0.0264},{"period":"6month","weight":0.1756},{"period":"1year","weight":0.2022},{"period":"ytd","weight":0.0418}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Argenx Se根据荷兰法律于2008年4月25日成立，是一家私人有限责任公司（besloten vennootschap met beperkte aansprakelijkheid）。 于2014年5月28日，根据公证转换契约及修订，该公司转为上市有限责任公司（naamloze vennootschap）。 该公司是一家处于商业阶段的、全球性的、完全整合的生物制药公司，开发用于治疗严重自身免疫性疾病的差异化疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.000942},{"month":2,"riseRate":0.428571,"avgChangeRate":0.053858},{"month":3,"riseRate":0.571429,"avgChangeRate":-0.014172},{"month":4,"riseRate":0.714286,"avgChangeRate":0.01936},{"month":5,"riseRate":0.666667,"avgChangeRate":0.100664},{"month":6,"riseRate":0.857143,"avgChangeRate":0.051985},{"month":7,"riseRate":0.571429,"avgChangeRate":0.05209},{"month":8,"riseRate":0.571429,"avgChangeRate":0.013188},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.040401},{"month":10,"riseRate":0.571429,"avgChangeRate":0.020323},{"month":11,"riseRate":0.714286,"avgChangeRate":0.125937},{"month":12,"riseRate":0.571429,"avgChangeRate":0.160659}],"exchange":"NASDAQ","name":"Argenx SE","nameEN":"Argenx SE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Argenx SE(ARGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Argenx SE(ARGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Argenx SE,ARGX,Argenx SE股票,Argenx SE股票老虎,Argenx SE股票老虎国际,Argenx SE行情,Argenx SE股票行情,Argenx SE股价,Argenx SE股市,Argenx SE股票价格,Argenx SE股票交易,Argenx SE股票购买,Argenx SE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Argenx SE(ARGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Argenx SE(ARGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}